"It is already known that we are facing a diabetes epidemic that will only grow worse in the next 10 to 20 years. The ability to identify patients at high risk years ahead of disease diagnosis may allow us to halt diabetes progression, saving lives and helping to maintain or improve the quality of life for our patients, while also reducing the overall expenses associated with the disease."

— Sean Sullivan, director of pharmaceutical outcomes research and policy at the University of Washington, discussing the need for an early warning test for diabetes, "Diabetes test gives 5-year disease-prediction window," pp. 1, 7.